RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.
Aaron A Smargon, Yilan J Shi, Gene W Yeo
Nature cell biology · 2020 · Vol. 22 (2) · pp. 143-150
Abstract
Deployment of RNA-guided DNA endonuclease CRISPR-Cas technology has led to radical advances in biology. As the functional diversity of CRISPR-Cas and parallel systems is further explored, RNA manipulation is emerging as a powerful mode of CRISPR-based engineering. In this Perspective, we chart progress in the RNA-targeting CRISPR-Cas (RCas) field and illustrate how continuing evolution in scientific discovery translates into applications for RNA biology and insights into mysteries, obstacles, and alternative technologies that lie ahead.
Funding 8 grants
| Grant | Funder |
|---|---|
| U24 HG009889 | NHGRI NIH HHS (United States) |
| R01 HG004659 | NHGRI NIH HHS (United States) |
| R01 NS103172 | NINDS NIH HHS (United States) |
| T32 EB009380 | NIBIB NIH HHS (United States) |
| U41 HG009889 | NHGRI NIH HHS (United States) |
| U19 MH107367 | NIMH NIH HHS (United States) |
| R01 EY029166 | NEI NIH HHS (United States) |
| R01 GM132106 | NIGMS NIH HHS (United States) |